Polatuzumab vedotin added to R-GemOx improved survival in relapsed/refractory diffuse large B-cell lymphoma, offering a new treatment option for transplant-ineligible patients. Histotripsy, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results